Trial Profile
A Comparison Of The Safety And Bioavailability Of Modified-Release Formulations Of Levodopa-Carbidopa In Subjects With Parkinson's Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2013
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 09 Aug 2011 New trial record